Terms: = Kidney tumors AND AKT2, PKBBETA, 208, ENSG00000105221, RAC-BETA, P31751, PRKBB AND Prognosis
16 results:
1. The prognostic impact of lymph node dissection for clinically node-negative upper urinary tract urothelial carcinoma in patients who are treated with radical nephroureterectomy.
Hsieh HC; Wang CL; Chen CS; Yang CK; Li JR; Wang SS; Cheng CL; Lin CY; Chiu KY
PLoS One; 2022; 17(12):e0278038. PubMed ID: 36454803
[TBL] [Abstract] [Full Text] [Related]
2. Role of Renin-Angiotensin System Blockers on BCG Response in Nonmuscle Invasive, High Risk Bladder Cancer.
Motterle G; Morlacco A; Giovannini G; Vecchiato E; Iafrate M; Calpista A; Prayer-Galetti T; Martino F; Dal Moro F; Novara G
Clin Genitourin Cancer; 2022 Aug; 20(4):e303-e309. PubMed ID: 35314138
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic relevance of ABO blood group system in non-metastatic renal cell carcinoma: An analysis of two independent European cohorts with long-term follow-up.
Barth DA; Sareban N; Lindner AK; Daller LAJ; Matzhold EM; Hutterer G; Smolle M; Mischinger J; Riedl JM; Seles M; Mannweiler S; Bauernhofer T; Pummer K; Pichler R; Zigeuner R; Schlenke P; Pichler M
Urol Oncol; 2021 Oct; 39(10):736.e9-736.e16. PubMed ID: 34247906
[TBL] [Abstract] [Full Text] [Related]
4. Chromosome 17p13 deletion is associated with an aggressive tumor phenotype in clear cell renal cell carcinoma.
Eichenauer T; Shadanpour N; Kluth M; Göbel C; Weidemann S; Fraune C; Büscheck F; Hube-Magg C; Möller-Koop C; Dahlem R; Fisch M; Rink M; Riechardt S; Burandt E; Bernreuther C; Minner S; Simon R; Sauter G; Wilczak W; Clauditz T
World J Surg Oncol; 2020 Jun; 18(1):128. PubMed ID: 32534597
[TBL] [Abstract] [Full Text] [Related]
5. Baseline Edmonton Symptom Assessment System and survival in metastatic renal cell carcinoma.
Graham J; Gingerich J; Lambert P; Alamri A; Czaykowski P
Curr Oncol; 2018 Aug; 25(4):e319-e323. PubMed ID: 30111978
[TBL] [Abstract] [Full Text] [Related]
6. CD34 immunostaining enhances a distinct pattern of intratumor angiogenesis with prognostic implications in clear cell renal cell carcinoma.
López JI; Erramuzpe A; Guarch R; Cortés JM; Pulido R; Llarena R; Angulo JC
APMIS; 2017 Feb; 125(2):128-133. PubMed ID: 28120493
[TBL] [Abstract] [Full Text] [Related]
7. Fibroblast activation protein predicts prognosis in clear cell renal cell carcinoma.
López JI; Errarte P; Erramuzpe A; Guarch R; Cortés JM; Angulo JC; Pulido R; Irazusta J; Llarena R; Larrinaga G
Hum Pathol; 2016 Aug; 54():100-5. PubMed ID: 27063470
[TBL] [Abstract] [Full Text] [Related]
8. Statins and survival outcomes in patients with metastatic renal cell carcinoma.
McKay RR; Lin X; Albiges L; Fay AP; Kaymakcalan MD; Mickey SS; Ghoroghchian PP; Bhatt RS; Kaffenberger SD; Simantov R; Choueiri TK; Heng DY
Eur J Cancer; 2016 Jan; 52():155-62. PubMed ID: 26687834
[TBL] [Abstract] [Full Text] [Related]
9. The relationship between the site of metastases and outcome in children with stage IV Wilms Tumor: data from 3 European Pediatric Cancer Institutions.
Berger M; Fernandez-Pineda I; Cabello R; Ramírez-Villar GL; Márquez-Vega C; Nustede R; Linderkamp C; Schmid I; Neth O; Graf N; de Agustin JC; von Schweinitz D; Lacher M; Hubertus J
J Pediatr Hematol Oncol; 2013 Oct; 35(7):518-24. PubMed ID: 23588334
[TBL] [Abstract] [Full Text] [Related]
10. Expression of CXCL14 and its anticancer role in breast cancer.
Gu XL; Ou ZL; Lin FJ; Yang XL; Luo JM; Shen ZZ; Shao ZM
Breast Cancer Res Treat; 2012 Oct; 135(3):725-35. PubMed ID: 22910931
[TBL] [Abstract] [Full Text] [Related]
11. Kattan postoperative nomogram for renal cell carcinoma: predictive accuracy in a Japanese population.
Suzuki K; Nishiyama T; Hara N; Akazawa K; Takahashi K
Int J Urol; 2011 Mar; 18(3):194-9. PubMed ID: 21226767
[TBL] [Abstract] [Full Text] [Related]
12. Reevaluation of renal cell carcinoma and perirenal fat invasion only.
Jeon HG; Jeong IG; Kwak C; Kim HH; Lee SE; Lee E
J Urol; 2009 Nov; 182(5):2137-43. PubMed ID: 19758661
[TBL] [Abstract] [Full Text] [Related]
13. Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas.
Klatte T; Patard JJ; de Martino M; Bensalah K; Verhoest G; de la Taille A; Abbou CC; Allhoff EP; Carrieri G; Riggs SB; Kabbinavar FF; Belldegrun AS; Pantuck AJ
J Urol; 2008 May; 179(5):1719-26. PubMed ID: 18343437
[TBL] [Abstract] [Full Text] [Related]
14. Evaluation of CD31 (PECAM-1) expression using tissue microarray in patients with renal cell carcinoma.
Sandlund J; Hedberg Y; Bergh A; Grankvist K; Ljungberg B; Rasmuson T
Tumour Biol; 2007; 28(3):158-64. PubMed ID: 17510564
[TBL] [Abstract] [Full Text] [Related]
15. The therapeutic value of adrenalectomy in case of solitary metastatic spread originating from primary renal cell cancer.
Kuczyk M; Wegener G; Jonas U
Eur Urol; 2005 Aug; 48(2):252-7. PubMed ID: 15936136
[TBL] [Abstract] [Full Text] [Related]
16. Expression of EphA2 is prognostic of disease-free interval and overall survival in surgically treated patients with renal cell carcinoma.
Herrem CJ; Tatsumi T; Olson KS; Shirai K; Finke JH; Bukowski RM; Zhou M; Richmond AL; Derweesh I; Kinch MS; Storkus WJ
Clin Cancer Res; 2005 Jan; 11(1):226-31. PubMed ID: 15671550
[TBL] [Abstract] [Full Text] [Related]
